Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 1/20 | 0.48 |
| ▸ | CXCR4 | P61073 | 4/20 | 0.45 |
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.45 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.45 |
| ▸ | RAMP3 | O60896 | 6/20 | 0.44 |
| ▸ | CALCR | P30988 | 6/20 | 0.44 |
| ▸ | MC4R | P32245 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 2/20 | 0.42 |
| ▸ | CTSS | P25774 | 2/20 | 0.42 |
| ▸ | CTSK | P43235 | 2/20 | 0.42 |
| ▸ | CTSH | P09668 | 1/20 | 0.42 |
| ▸ | KLK7 | P49862 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29963046 | 0.93 | CXCR4 (0.47) | NAA50CXCR4NMUR2NMUR1RAMP3 | |
| SCHEMBL30937368 | 0.87 | RAMP3 (0.44) | NAA50CXCR4NMUR2NMUR1RAMP3 | |
| SCHEMBL31303212 | 0.87 | CXCR4 (0.50) | CXCR4NMUR2NMUR1RAMP3CALCR | |
| SCHEMBL29788350 | 0.85 | NMUR2 (0.49) | CXCR4NMUR2NMUR1RAMP3CALCR | |
| SCHEMBL30518019 | 0.85 | NMUR2 (0.51) | NAA50CXCR4NMUR2NMUR1RAMP3 | |
| SCHEMBL30518008 | 0.85 | NMUR2 (0.51) | NAA50CXCR4NMUR2NMUR1RAMP3 | |
| SCHEMBL30518138 | 0.85 | NMUR2 (0.51) | NAA50CXCR4NMUR2NMUR1RAMP3 | |
| SCHEMBL31481586 | 0.85 | OPRK1 (0.47) | NMUR2NMUR1 | |
| SCHEMBL29564535 | 0.84 | CXCR4 (0.40) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL9616909 | 0.84 | OPRK1 (0.43) | CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12152182-B2 | Polymer nanoparticles for afterglow molecular imaging | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12152182-B2 | Polymer nanoparticles for afterglow molecular imaging | CD68, ALG1, MB | NAA50 3414/4885CXCR4 3758/4885NMUR2 1188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.